Considering that TNBC is associated with lower DNA repair capacity among breast cancer subtypes 20 and TNBC cell lines exhibited the highest TOP1 inhibition sensitivity 7, we attempted to elucidate the mechanism underlying cancer cell response to TOP1 blockade in the hope of paving the way for further developing and optimizing TOP1-targeted therapy for breast cancers. This evidence concerns the gene TOP1 and cancer.